Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Igm Biosciences Inc (IGMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2019	12-2018	12-2017	12-2006
Cash Flows From Operating Activities
Net Income	-43,133	-22,711	-11,054	N/A
Depreciation Amortization	291	278	161	N/A
Accounts payable and accrued liabilities	1,961	-61	128	N/A
Other Working Capital	-5,024	2,179	443	N/A
Other Operating Activity	789	271	-35	0
Operating Cash Flow	$-45,116	$-20,044	$-10,357	$N/A

Cash Flows From Investing Activities
PPE Investments	-2,337	-788	-385	N/A
Purchase Of Investment	-208,901	N/A	0	N/A
Sale Of Investment	8,000	N/A	N/A	N/A
Investing Cash Flow	$-203,238	$-788	$-385	$N/A

Cash Flows From Financing Activities
Change In Short Term Borrowing	15,000	5,000	N/A	N/A
Common Stock Issued	187,352	N/A	3	N/A
Other Financing Activity	79,906	17,337	8,065	0
Financing Cash Flow	$282,258	$22,337	$8,068	$N/A

Beginning Cash Position	1,987	482	3,156	N/A
End Cash Position	35,891	1,987	482	N/A
Net Cash Flow	$33,904	$1,505	$-2,674	$N/A

Free Cash Flow
Operating Cash Flow	-45,116	-20,044	-10,357	N/A
Capital Expenditure	-2,337	-788	-385	N/A
Free Cash Flow	-47,453	-20,832	-10,742	0